This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

March Is Kidney Cancer Awareness Month

WASHINGTON, D.C., March 21, 2013 /PRNewswire/ -- Kidney Cancer Association (KCA), with its more than 70,000 members worldwide, are celebrating by honoring the many collaborators who have helped to make KCA a global leader.

March is Kidney Cancer Awareness Month and the Kidney Cancer Association (KCA), with its more than 70,000 members worldwide, are celebrating by honoring the many collaborators who have helped to make ours the largest organization of its kind.Since its founding in 1990 by the late Eugene P. Schonfeld, Ph.D., KCA has developed scores of highly effective relationships with organizations and institutions around the world. Carrie Konosky, KCA vice president for development, says, "By working with others who specialize in helping people whose lives have been touched by renal cancers, we've made remarkable strides in the development of new medicines, along with advancements in surgical interventions, and helping patient families with the psycho-social aspects of dealing with the disease."Among the earliest of collaborations were those that brought medical experts on board as advisers to KCA. Doctors and researchers from University of Chicago, Loyola University, Cleveland Clinic, M. D. Anderson Cancer Center, and other major academic centers were a part of the first to join this effort. Soon faculty from West Coast institutions joined, followed by doctors from the major European centers.In the 1990s, KCA joined the renowned Washington, D.C. based Cancer Leadership Council, where others with a shared interest in the eradication of death and suffering from cancer gather monthly to work on a common advocacy agenda. Members of KCA have served on the governing board of Friends of Cancer Research, and as advisers to the director of the National Cancer Institute (NCI) through the Director's Consumer Liaison Group.KCA's longstanding affiliation with Patient Advocate Foundation enables families to receive prompt assistance with questions related to health insurance, as well as co-pay assistance for drugs.Nurses working in the biotherapy unit at Providence Portland Medical Center answer patients' questions related to side-effects from medical treatments and also provide referrals to expert physicians."Obviously, there are too many KCA collaborations for us to list in a single press release," Konosky adds. "These relationships will be evident to anyone who visits our website at Recently, we began working with Lotsa Helping Hands, a group that facilitates online connections for families that need help dealing with routine tasks because of a loved one's experience with kidney cancer."Earlier this year, KCA initiated collaborations with two groups that help patients to raise funds for medical expenses. Details are available on the KCA website, where information about one-to-one patient support through may also be found.KCA CEO, Bill Bro, a 24-year kidney cancer survivor, serves as a member of NCI's Renal Cancer Task Force, as well as an adviser to the Kidney Cancer SPORE, a federally funded program of research excellence based in Boston."During Kidney Cancer Awareness Month, we want to make the people we serve aware of the numerous collaborations that KCA has developed to assist people who are dealing with cancer. Our highly effective partnering with major cancer foundations has resulted in the funding of numerous research awards to young investigators who are rapidly becoming 'super stars' in this field. Truly, together we are stronger," says Bro.


Kidney Cancer AssociationKCA PR Office

SOURCE Kidney Cancer Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs